Featured Research

from universities, journals, and other organizations

Less than 1% of UK public research funding spent on antibiotic research in past 5 years

Date:
July 25, 2014
Source:
The Lancet
Summary:
Less than 1% of research funding awarded by public and charitable bodies to UK researchers in 2008–13 was awarded for research on antibiotics, according to new research. The study, which is the first detailed assessment of public and charitable funding to UK researchers focusing on bacteriology and antibiotic research, suggests that present levels of funding for antibiotic research in the UK are inadequate, and will need to be urgently increased if the growing crisis of antibiotic resistance is to be tackled effectively by UK researchers.

Less than 1% of research funding awarded by public and charitable bodies to UK researchers in 2008-13 was awarded for research on antibiotics, according to new research published in The Lancet Infectious Diseases. The study, which is the first detailed assessment of public and charitable funding to UK researchers focusing on bacteriology and antibiotic research, suggests that present levels of funding for antibiotic research in the UK are inadequate, and will need to be urgently increased if the growing crisis of antibiotic resistance is to be tackled effectively by UK researchers.

According to lead author Professor Laura Piddock, of the University of Birmingham, UK, "The message that antibacterial (ie, antibiotic) drug resistance has become a world health crisis has been brought to global attention by WHO, the European Union (EU), the World Economic Forum, and, most recently, the UK Chief Medical Officer. As a world leader in biomedical research, UK research has an important part to play in tackling this crisis. However, our study clearly shows that the proportion of public and charitable funding for research into new antibiotics, understanding resistance mechanisms and ways of tackling resistance are inadequate for the size of the task."

Professor Piddock and her colleague analysed funding databases for the UK's main research funding organisations [1], finding that of 138 billion total available research funding, 269 million (19%) was awarded to bacteriology projects, and around a third of this (95 million or 07% of total funding) was awarded for research on antibiotics. Additionally, 181 million in EU funding was awarded to antibiotic research consortia including researchers based within the UK, including two EU Innovative Medicines Initiative awards, totalling 85 million.

While this article focused exclusively on research funding for antibiotics, previous studies have shown that funding for other antimicrobials (antifungals and antivirals) is similarly low as a proportion of total funding.

As well as demonstrating that the proportion of research funding given for UK antibiotic research will need to increase, the authors suggest that publically available, subject-specific, funding databases will allow investment in priority areas to be tracked in future.

"Since 2011, most new EU funding has focused on public-private partnerships with industry," adds Professor Piddock. "However, an increased understanding about antibiotic resistance is needed, not least to inform strategies to both minimise and prevent antibiotic-resistant bacteria arising when new treatments become available."

In a linked Comment, Dr Michael G Head from the Farr Institute, University College London, UK, said "The private sector needs to be more transparent about how much they invest in areas related to antibiotics (generation of new therapeutics being an obvious and particularly important area), so that their data can be similarly analysed in detail. Efforts to document the investments of other countries regarding antibiotic resistance research would be beneficial and would allow funders and policymakers to chart the optimum future direction of research money. Metrics to establish the true burden of antibiotic resistance and methods also to assess the likely effect of other types of research are needed; for example, preventive research such as vaccine development will affect future burdens of bacterial infections and resistance."


Story Source:

The above story is based on materials provided by The Lancet. Note: Materials may be edited for content and length.


Journal Reference:

  1. Eilis C Bragginton, Laura J V Piddock. UK and European Union public and charitable funding from 2008 to 2013 for bacteriology and antibiotic research in the UK: an observational study. The Lancet Infectious Diseases, 2014; DOI: 10.1016/S1473-3099(14)70825-4

Cite This Page:

The Lancet. "Less than 1% of UK public research funding spent on antibiotic research in past 5 years." ScienceDaily. ScienceDaily, 25 July 2014. <www.sciencedaily.com/releases/2014/07/140725080339.htm>.
The Lancet. (2014, July 25). Less than 1% of UK public research funding spent on antibiotic research in past 5 years. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2014/07/140725080339.htm
The Lancet. "Less than 1% of UK public research funding spent on antibiotic research in past 5 years." ScienceDaily. www.sciencedaily.com/releases/2014/07/140725080339.htm (accessed September 20, 2014).

Share This



More Science & Society News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Climate Change Rally Held in India Ahead of UN Summit

Climate Change Rally Held in India Ahead of UN Summit

AFP (Sep. 20, 2014) Some 125 world leaders are expected to commit to action on climate change at a UN summit Tuesday called to inject momentum in struggling efforts to tackle global warming. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
U.S. Food Makers Surpass Calorie-Cutting Pledge

U.S. Food Makers Surpass Calorie-Cutting Pledge

Newsy (Sep. 18, 2014) Sixteen large food and beverage companies in the United States that committed to cut calories in their products far surpassed their target. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins